Actualités

Tous les liens de cette page renvoient vers des résumés d’articles (abstracts). L’ensemble des versions intégrales sont disponibles au Centre de Psychiatrie Interventionnelle. Vous pouvez également les consulter ou les acheter sur le site de l’éditeur.

PSYCHIATRIE INTERVENTIONNELLE EN SUISSE

Société suisse de psychiatrie interventionnelle (SSPI)

Autres spécialistes en Suisse

INFORMATIONS GÉNÉRALES SUR LA TMS

EFFICACITÉ ET SÉCURITÉ DE LA TMS

EFFICACITÉ DE LA TMS DANS LA DÉPRESSION

EFFICACITÉ DE LA TMS DANS D’AUTRES INDICATIONS

EFFICACITÉ DE L’ECT DANS LA DÉPRESSION

ECT ET TROUBLE BIPOLAIRE

ECT ET SCHIZOPHRÉNIE

AUDIO & VIDEO

KÉTAMINE ET DÉPRESSION

A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. (American Journal of Psychiatry)

Low-dose ketamine for treatment resistant depression in an academic clinical practice setting(journal of affective disorders)

Kétamine comme option thérapeutique (Swiss Medical Forum)

How club drug ketamine fights depression (Nature)

Rave drug holds promise for treating depression fast (Nature)

ketamine: stimulating antidepressant treatment? (British Journal of Psychiatry)

Ketamine for treatment-resistant unipolar and bipolar major depression: critical review and implications for clinical practice (Depression and Anxiety)

Ketamine for treatment-resistant depression: recent developments and clinical applications. (British Medical Journal)

Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment. (American Journal of Psychiatry)

Ketamine: a potential rapid-acting antisuicidal agent? (Depression and Anxiety)

NMDAR inhibition-independent antidepressant actions of ketamine metabolites. (Nature)

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. (Journal of Affective Disorders)

Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. (Journal of Affective Disorders)

Administration of ketamine for unipolar and bipolar depression. (International Journal of Psychiatry in Clinical Practice)

What is the mechanism of Ketamine’s rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. (Journal of clinical pharmacy and therapeutics)

Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression. (Journal of Clinical Psychiatry)

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature. (The Mental Health Clinician)

Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity. (Journal of Psychopharmacology)

KÉTAMINE DANS D’AUTRES INDICATIONS

ESKÉTAMINE INTRANASALE ET DEPRESSION

ECT : SECURITÉ, MÉCANISMES, EFFETS SECONDAIRES

Neuropathological evaluation of an 84-year-old man after 422 ECT treatments. (Journal of ECT)

Electroconvulsive therapy increases temporal gray matter volume and cortical thickness. (European Neuropsychopharmacology)

Objective Cognitive Performance Associated with Electroconvulsive Therapy for  Depression: A Systematic Review and Meta-Analysis. (Biological Psychiatry)

Evaluation of cumulative cognitive deficits from electroconvulsive therapy. (British Journal of Psychiatry).

An Examination of Mortality and Other Adverse Events Related to Electroconvulsive Therapy Using a National Adverse Event Report System. (Journal of ECT)

Neurotransmitters and Electroconvulsive Therapy. (Journal of ECT)

Hippocampal Neurogenesis and Antidepressive Therapy: Shocking Relations. (Neural Plasticity)

Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study. (Journal of Psychiatry & Neuroscience)

Effect of electroconvulsive therapy on gray matter volume in major depressive disorder. (Journal of Affective Disorders)

Mechanisms of Antidepressant Response to Electroconvulsive Therapy Studied With Perfusion Magnetic Resonance Imaging. (Biological Psychiatry)

Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression. (Brain Stimulation)

Long-Term Cognitive and Psychological Functioning in Post–Electroconvulsive Therapy Patients. (Journal of ECT)

Electroconvulsive therapy and risk of dementia in patients with affective disorders – a cohort study. (Lancet Psychiatry)